Global Ventral Hernia Treatment Market
HealthcareServices

Ventral Hernia Treatment Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Ventral Hernia Treatment Market Size Shifted, And What Is the Outlook Through 2034?

The market size for ventral hernia treatment has seen substantial expansion over recent years. The growth is projected to increase from $4.87 billion in 2024 to reach $5.22 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The phenomenal growth during the historical period can be credited to the rise in obesity cases, greater awareness about ventral hernias, the growing population of elderly people, increasing disposable income, and the rising demand for less invasive surgical procedures.

Over the coming years, substantial expansion is anticipated in the ventral hernia treatment market, with projections indicating a surge to$6.84 billion in 2029″ at a compound annual growth rate (CAGR) of 7.0%. The surge during this projected period is associated with factors such as growing preference for outpatient procedures, escalating healthcare expenditures, increased government initiatives, rising demand for hernia repair surgeries, and a boost in research and development investment. Key trends expected to shape the market within the forecast period comprise advanced hernia repair gadgets, bioabsorbable materials, strategic collaborations, robot-assisted surgical equipment, and remote monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What External and Internal Drivers Are Contributing to the Growth of theVentral Hernia Treatment Market?

The escalating rates of obesity are set to catalyze the expansion of the ventral hernia treatment market. Defined by an excessive accumulation of body fat that significantly affects an individual’s health, obesity prevalence is spurred by factors such as poor diet, inactive lifestyle, genetic propensity, inadequate physical exercise, environmental factors, and emotional stress. By tackling obesity-induced complications, ventral hernia treatments aid in reducing pressure on the abdominal wall, minimizing the likelihood of hernia recurrence, and bolstering overall abdominal robustness. These are critical factors in aiding mobility and fostering healthier lifestyle decisions in individuals battling obesity. For instance, the Switzerland-based intergovernmental organization, World Health Organization (WHO), revealed in March 2024 that around one in eight people globally were grappling with obesity. This included 2.5 billion adults (18 years and above) who were overweight, of which 890 million were obese. Among adults, 43% were overweight, while 16% were categorized as obese. Additionally, the figure for overweight children under the age of 5 stood at 37 million. Hence, the escalating rates of obesity accelerates the growth of the ventral hernia treatment market.

What Segment Types Define the Ventral Hernia Treatment Market Structure?

The ventral hernia treatmentmarket covered in this report is segmented –

1) By Type: Epigastric (Stomach Area) Hernia; Umbilical (Belly Button) Hernia; Incisional Hernia

2) By Diagnosis: Ultrasound; Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI)

3) By Surgery: Open Hernia Surgery; Laparoscopic Surgery; Robotic Hernia Surgery

4) By End Users: Hospitals; Ambulatory Surgical Centres; Clinics

Subsegments:

1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia; Large Epigastric Hernia

2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia; Acquired Umbilical Hernia

3) By Incisional Hernia: Primary Incisional Hernia; Recurrent Incisional Hernia

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21315&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Ventral Hernia Treatment Market?

North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Ventral Hernia Treatment Market?

Prominent corporations in the ventral hernia treatment industry are prioritizing cutting-edge technology such as laparoscopic and open hernia mesh fixation devices, to boost surgical success, lower the risk of complications, and streamline patient recovery. These devices are essentially medical equipment leveraged to stabilize mesh during hernia repair operations, whether through minimally invasive (laparoscopic) or conventional open surgical methods. For example, in March 2024, TELA Bio Inc., an American medical technology enterprise, unveiled the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in America. LIQUIFIX FIX8 is designed for minimally invasive repairs, whilst LIQUIFIX precision is intended for open femoral and inguinal hernia repairs. These FDA-endorsed devices incorporate liquid anchors to secure mesh without invading tissue, thereby minimizing trauma and complications. With more than 1.2 million hernia surgeries carried out in the U.S. every year, LIQUIFIX offers accuracy and safety in delicate areas, and decreases the chances of damage to blood vessels or nerves.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

What Is the Definition of the Ventral Hernia Treatment Market?

Ventral hernia treatment refers to the medical procedures and interventions used to repair hernias that occur in the abdominal wall. It typically involves the use of robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal. The treatment aims to reposition displaced tissues, strengthen the abdominal wall, and prevent recurrence. These treatments are used to relieve pain, restore normal function, and reduce the risk of complications such as bowel obstruction or strangulation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model